Skip to content
Altabax, Altargo(retapamulin)
Altabax, Altargo (retapamulin) is a small molecule pharmaceutical. Retapamulin was first approved as Altabax on 2007-04-12. It is used to treat bacterial infections and impetigo in the USA. It has been approved in Europe to treat impetigo and staphylococcal skin infections.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Altabax
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Retapamulin
Tradename
Company
Number
Date
Products
ALTABAXAlmirallN-022055 RX2007-04-12
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
altabaxNew Drug Application2019-09-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
impetigoEFO_1000714D007169L01
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Retapamulin, Altabax, Almirall
78756302027-02-14DP
82071912024-08-30U-805
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AX: Other antibiotics for topical use in atc
— D06AX13: Retapamulin
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bacterial infectionsD001424A49———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameRETAPAMULIN
INNretapamulin
Description
Retapamulin is a carbotricyclic compound, a carboxylic ester and a cyclic ketone.
Classification
Small molecule
Drug classantibacterials, pleuromulin derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Identifiers
PDB—
CAS-ID224452-66-8
RxCUI—
ChEMBL IDCHEMBL1658
ChEBI ID—
PubChem CID6918462
DrugBankDB01256
UNII ID4MG6O8991R (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 549 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3 adverse events reported
View more details